These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 17619614)

  • 1. [EEG and clinical psychophysiological study of functional changes in the chronic ischemic brain with increased acetylcholinergic activity].
    Sorokina ND; Selitskiĭ GV; Kositsyn NS
    Fiziol Cheloveka; 2007; 33(3):35-9. PubMed ID: 17619614
    [No Abstract]   [Full Text] [Related]  

  • 2. Galantamine treatment of vascular dementia: a randomized trial.
    Auchus AP; Brashear HR; Salloway S; Korczyn AD; De Deyn PP; Gassmann-Mayer C;
    Neurology; 2007 Jul; 69(5):448-58. PubMed ID: 17664404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The use of reminyl (galantamine) in the treatment of probable vascular dementia].
    Mokhova OI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(9):77-9. PubMed ID: 19911468
    [No Abstract]   [Full Text] [Related]  

  • 4. Vascular dementia: pharmacological treatment approaches and perspectives.
    Baskys A; Hou AC
    Clin Interv Aging; 2007; 2(3):327-35. PubMed ID: 18044183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Traditional dementia concepts in transition--must we change our views?].
    Nervenarzt; 2005 Sep; 76(9):2p following 1164. PubMed ID: 16320378
    [No Abstract]   [Full Text] [Related]  

  • 6. Cognitive decline and treatment options for patients with vascular dementia.
    Erkinjuntti T
    Acta Neurol Scand Suppl; 2002; 178():15-8. PubMed ID: 12492787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences exist in the cognitive profile of mild Alzheimer's disease and subcortical ischemic vascular dementia.
    Kandiah N; Narasimhalu K; Lee J; Chen CL
    Dement Geriatr Cogn Disord; 2009; 27(5):399-403. PubMed ID: 19339778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain activation in elderly people with and without dementia: Influences of gender and medication.
    Richter MM; Herrmann MJ; Ehlis AC; Plichta MM; Fallgatter AJ
    World J Biol Psychiatry; 2007; 8(1):23-9. PubMed ID: 17366346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dl-3-n-butylphthalide can improve the cognitive function of patients with acute ischemic stroke: a prospective intervention study.
    Yan H; Yan Z; Niu X; Wang J; Gui Y; Zhang P
    Neurol Res; 2017 Apr; 39(4):337-343. PubMed ID: 28145815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholinergic precursors in the treatment of cognitive impairment of vascular origin: ineffective approaches or need for re-evaluation?
    Parnetti L; Mignini F; Tomassoni D; Traini E; Amenta F
    J Neurol Sci; 2007 Jun; 257(1-2):264-9. PubMed ID: 17331541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of galantamine to treat vascular dementia.
    Moretti R; Torre P; Antonello RM; Cazzato G; Bava A
    Lancet; 2002 Nov; 360(9344):1512-3; author reply 1513. PubMed ID: 12433549
    [No Abstract]   [Full Text] [Related]  

  • 12. Citicoline in vascular cognitive impairment and vascular dementia after stroke.
    Alvarez-Sabín J; Román GC
    Stroke; 2011 Jan; 42(1 Suppl):S40-3. PubMed ID: 21164117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electroencephalographic effects of galantamine in major depressive disorder.
    Elgamal SA; Marriott M; Macqueen GM
    J Clin Neurophysiol; 2009 Jun; 26(3):192-7. PubMed ID: 19424085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychiatric disease in the twenty-first century: The case for subcortical ischemic depression.
    Taylor WD; Steffens DC; Krishnan KR
    Biol Psychiatry; 2006 Dec; 60(12):1299-303. PubMed ID: 17014829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [EEG correlates of mild impairments in higher cortical functions].
    Iznak AF; Zhigul'skaia SE; Gorbachevskaia NL; Vasil'eva AG; Chaianov NV; Gavrilova SI; Roshchina IF; Kolykhalov IV; Zharikov GA
    Fiziol Cheloveka; 2001; 27(1):5-13. PubMed ID: 11247513
    [No Abstract]   [Full Text] [Related]  

  • 16. Galantamine improves gait performance in patients with Alzheimer's disease.
    Assal F; Allali G; Kressig RW; Herrmann FR; Beauchet O
    J Am Geriatr Soc; 2008 May; 56(5):946-7. PubMed ID: 18454755
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of galantamine to treat vascular dementia.
    van Gool WA
    Lancet; 2002 Nov; 360(9344):1512; author reply 1513. PubMed ID: 12433548
    [No Abstract]   [Full Text] [Related]  

  • 18. Vascular dementia: galantamine (Reminyl) as an emerging therapeutic option.
    Small GW
    Acta Neurol Scand Suppl; 2002; 178():4-5. PubMed ID: 12492784
    [No Abstract]   [Full Text] [Related]  

  • 19. Galantamine treatment in Alzheimer's disease with cerebrovascular disease: responder analyses from a randomized, controlled trial (GAL-INT-6).
    Erkinjuntti T; Gauthier S; Bullock R; Kurz A; Hammond G; Schwalen S; Zhu Y; Brashear R
    J Psychopharmacol; 2008 Sep; 22(7):761-8. PubMed ID: 18308781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An unusual case of nightmares with galantamine.
    Iraqi A; Hughes TL
    J Am Geriatr Soc; 2009 Mar; 57(3):565. PubMed ID: 19278402
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.